Dr. Call is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3838 S 700 E
Ste 100
Salt Lake City, UT 84106Phone+1 801-269-0231Fax+1 801-269-0304- Is this information wrong?
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of ColoradoResidency, Internal Medicine, 2001 - 2004
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2001
Certifications & Licensure
- UT State Medical License 2012 - 2026
- MI State Medical License 2008 - 2015
- CO State Medical License 2004 - 2013
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy Start of enrollment: 2019 Dec 15
- PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001) Start of enrollment: 2023 Mar 15
Roles: Contact
Publications & Presentations
PubMed
- 13 citationsARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study.Melissa Johnson, Arkadiusz Z Dudek, Ammar Sukari, Justin Call, Paul R Kunk, Karl Lewis, Justin F Gainor, John Sarantopoulos, Patrice Lee, Adele Golden, Allison Harney,...> ;Clinical Cancer Research. 2022 Jun 13
- 69 citationsParsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.Andres Forero-Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub, Michael S. Wertheim, William Jeffery Edenfield, Paolo Caimi, Martin Gutierrez, Luke P. Akard, Caro...> ;Blood. 2019 Apr 18
- 364 citationsNeratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3..., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. Oncology. 2017 Dec 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Lakeview HospitalBountiful, Utah
- Holy Cross Hospital - Salt LakeSalt Lake City, Utah
- Intermountain Medical CenterSalt Lake City, Utah
- St. Mark's HospitalSalt Lake City, Utah
- Riverton HospitalRiverton, Utah
- LDS HospitalSalt Lake City, Utah
- Alta View HospitalSandy, Utah
- American Fork HospitalAmerican Fork, Utah
- Utah Valley HospitalProvo, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: